Stage III Thymoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer (NCT00718809) | National Cancer Institute (NCI) | 2008-06-01 |
Track Stage III Thymoma automatically
Every clearance here is in the API, with alerts when new ones post.